共 50 条
- [21] Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Corona Stentinc: Insights From CHAMPIONCIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (03) : E011069Peterson, Benjamin E.Harrington, Robert A.Stone, Gregg W.Steg, Ph GabrielGibson, C. MichaelHamm, Christian W.Price, Matthew J.Lopes, Renato D.Leonardi, SergioPrats, JayneDeliargyris, Efthymios N.Mahaffey, Kenneth W.White, Harvey D.Bhatt, Deepak L.
- [22] REDUCED IMMEDIATE ISCHEMIC EVENTS WITH CANGRELOR IN PCI USING THE UNIVERSAL DEFINITION OF MI: POOLED ANALYSIS OF THE CANGRELOR VERSUS STANDARD THERAPY TO ACHIEVE OPTIMAL MANAGEMENT OF PLATELET INHIBITION TRIALSJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1097 - E1097White, Harvey D.Chew, Derek P.Dauerman, Harold L.Mahaffey, Kenneth W.Gibson, C. MichaelHarrington, Robert A.Bhatt, Deepak L.
- [23] Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention The CHAMPION PHOENIX TrialJACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (18) : 1905 - 1913Abtan, JeremieSteg, P. GabrielStone, Gregg W.Mahaffey, Kenneth W.Gibson, C. MichaelHamm, Christian W.Price, Matthew J.Abnousi, FreddyPrats, JayneDeliargyris, Efthymios N.White, Harvey D.Harrington, Robert A.Bhatt, Deepak L.
- [24] Pharmacodynamic Effects of Cangrelor and Clopidogrel: The Platelet Function Substudy from the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition in Patients Undergoing Percutaneous Coronary Intervention (CHAMPION-PCI) TrialCIRCULATION, 2011, 124 (21)Angiolillo, Dominick J.Schneider, David J.Bhatt, Deepak L.French, William J.Price, Matthew J.Saucedo, Jorge F.Shaburishvili, TamazHuber, KurtPrats, JayneLiu, TiepuHarrington, Robert A.Becker, Richard
- [25] Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trialsJournal of Thrombosis and Thrombolysis, 2015, 40 : 317 - 322Dominick J. AngiolilloDeepak L. BhattPh. Gabriel StegGregg W. StoneHarvey D. WhiteC. Michael GibsonChristian W. HammMatthew J. PriceJayne PratsTiepu LiuKenneth W. MahaffeyRobert A. Harrington
- [26] IMPACT OF CANGRELOR OVERDOSING ON BLEEDING COMPLICATIONS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CHAMPION TRIALSJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1905 - A1905Angiolillo, Dominick J.Bhatt, DeepakSteg, PhilippeStone, GreggWhite, HarveyGibson, C. MichaelHamm, ChristianPrice, MatthewPrats, JayneLiu, TiepuDay, JonathanMahaffey, KennethHarrington, Robert
- [27] THE EFFECT OF PLATELET INHIBITON BY CANGRELOR AMONG OBESE PATIENTS UNDERGOING CORONARY STENTING: INSIGHTS FROM THE CHAMPION TRIALSJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1333 - 1333Peterson, BenHarrington, RobertStone, GreggSteg, Philippe GabrielGibson, C. MichaelHamm, ChristianPrice, MatthewLopes, RenatoLeonardi, SergioPrats, JayneDeliargyris, EfthymiosMahaffey, KennethWhite, HarveyBhatt, Deepak L.
- [28] Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trialsJOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 40 (03) : 317 - 322Angiolillo, Dominick J.Bhatt, Deepak L.Steg, Ph. GabrielStone, Gregg W.White, Harvey D.Gibson, C. MichaelHamm, Christian W.Price, Matthew J.Prats, JayneLiu, TiepuMahaffey, Kenneth W.Harrington, Robert A.
- [29] Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention - Insights from the CHAMPION programAMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2021, 9Gutierrez, J. AntonioHarringtonc, Robert A.Stoned, Gregg W.Steg, Ph. GabrielGibson, C. MichaelHamm, Christian W.Price, Matthew J.Lopesi, Renato D.Leonardij, SergioPrats, JayneDeliargyris, Efthymios N.Mahaffeyc, Kenneth W.Whitem, Harvey D.Bhattb, Deepak L.